Leap Therapeutics Inc (LPTX)
3.19
+0.02
(+0.63%)
USD |
NASDAQ |
May 03, 16:00
3.23
+0.04
(+1.25%)
After-Hours: 20:00
Leap Therapeutics Price: 3.19 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 3.27 | 3.28 | 3.01 | 3.19 | 334593.0 |
May 02, 2024 | 3.31 | 3.35 | 3.05 | 3.17 | 137458.0 |
May 01, 2024 | 3.14 | 3.29 | 3.11 | 3.27 | 151424.0 |
Apr 30, 2024 | 3.07 | 3.289 | 3.018 | 3.10 | 105872.0 |
Apr 29, 2024 | 3.26 | 3.400 | 3.03 | 3.07 | 130420.0 |
Apr 26, 2024 | 3.29 | 3.39 | 2.99 | 3.25 | 403202.0 |
Apr 25, 2024 | 3.19 | 3.29 | 3.11 | 3.17 | 213233.0 |
Apr 24, 2024 | 3.20 | 3.30 | 3.10 | 3.29 | 200614.0 |
Apr 23, 2024 | 3.21 | 3.33 | 3.09 | 3.20 | 89131.00 |
Apr 22, 2024 | 2.86 | 3.26 | 2.85 | 3.21 | 328700.0 |
Apr 19, 2024 | 2.99 | 3.04 | 2.77 | 2.80 | 213807.0 |
Apr 18, 2024 | 2.99 | 3.06 | 2.89 | 2.96 | 101762.0 |
Apr 17, 2024 | 2.94 | 3.135 | 2.924 | 3.00 | 146417.0 |
Apr 16, 2024 | 3.04 | 3.20 | 2.95 | 2.98 | 151233.0 |
Apr 15, 2024 | 3.24 | 3.49 | 2.752 | 3.00 | 521740.0 |
Apr 12, 2024 | 3.15 | 3.50 | 3.07 | 3.24 | 565262.0 |
Apr 11, 2024 | 3.50 | 4.39 | 3.03 | 3.115 | 5.676M |
Apr 10, 2024 | 3.28 | 3.38 | 2.91 | 3.04 | 435708.0 |
Apr 09, 2024 | 2.60 | 3.59 | 2.59 | 3.41 | 1.358M |
Apr 08, 2024 | 2.55 | 2.64 | 2.53 | 2.58 | 68225.00 |
Apr 05, 2024 | 2.49 | 2.573 | 2.45 | 2.54 | 67432.00 |
Apr 04, 2024 | 2.57 | 2.655 | 2.42 | 2.51 | 95092.00 |
Apr 03, 2024 | 2.60 | 2.60 | 2.42 | 2.53 | 128899.0 |
Apr 02, 2024 | 2.75 | 2.75 | 2.58 | 2.63 | 83983.00 |
Apr 01, 2024 | 2.69 | 2.75 | 2.55 | 2.75 | 153697.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.30
Minimum
Oct 02 2023
40.10
Maximum
Sep 30 2021
13.79
Average
14.90
Median
Aug 23 2019
Price Benchmarks
Cutera Inc | 2.53 |
OrthoPediatrics Corp | 32.83 |
AIM ImmunoTech Inc | 0.4048 |
Protalix BioTherapeutics Inc | 1.14 |
Armata Pharmaceuticals Inc | 2.49 |
Price Related Metrics
PS Ratio | 43.43 |
Price to Book Value | 1.358 |
Earnings Yield | -151.1% |
Market Cap | 81.66M |